Both in Pharmaceuticals
Lexicon Pharmaceuticals vs Avalo Therapeutics
Over the past year LXRX returned +35.3% and AVTX returned +19.7%; their daily moves had a correlation of 0.25.
LXRX +35.3% AVTX +19.7%Growth of $1, one year, split-adjusted
| Metric | LXRX | AVTX |
|---|---|---|
| Price | $1.88 | $15.58 |
| Market cap | $836.5M | $835.6M |
| Today | −1.05% | +3.32% |
| 1 month | −17.9% | −20.5% |
| 6 months | +24.5% | +11.8% |
| Year to date | +63.5% | −14.2% |
| 1 year | +34.3% | +44.3% |
| Revenue growth (YoY) | −97.6% | — |
| Gross margin | 94.4% | — |
| Net margin | −4591.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 20.2× | 14,162.0× |
| Net cash | $139.2M | $400.3M |
| Dividend yield | — | — |
| Volatility (60d) | 55.0% | 54.8% |
| Short % of float | 12.7% | 24.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).